Far-Reaching Implications: Scientists Shed Light on the “Original Antigenic Sin”
According to the theory of original antigenic sin (OAS), our immune systems react most strongly to the viral strains we encountered in our childhoods. This…
According to the theory of original antigenic sin (OAS), our immune systems react most strongly to the viral strains we encountered in our childhoods. This…
A new study suggests that the way a baby is delivered may impact their immune system’s response to two key childhood vaccines. Babies who are…
The findings indicate that new antibody therapies must be developed. Are the currently approved antibody therapies used to treat patients who have a higher risk…
Freiburg and Harvard University researchers have revealed the three-dimensional structure of the B cell antigen receptor, providing new insight into its composition. B cells have…
While both protect from severe disease, inactivated SARS-CoV-2 and spike mRNA COVID-19 vaccines trigger different T-cell responses. Although the total magnitude of the T-cell responses…
Scientists have developed a new promising potential treatment for Alzheimer’s disease. According to a team of researchers from the University of Texas Health Houston, a…
Future vaccine development may be inspired by new research findings. Scientists at Boston Children’s Hospital have created an antibody, SP1-77, that successfully neutralizes all tested…
Researchers discovered which mutations of the Omicron SARS-CoV-2 virus make it more efficient at infecting cells and evading antibodies by using virus-like particles. As the…
The structure of many important molecules involved in anaphylaxis to mammalian meat has been uncovered, opening the door to potential future treatments. The genetic and…
Breastfeeding provides an immune boost to infants A recent study by Katherine Wander, an associate professor of anthropology at Binghamton University, suggests that breastfeeding strengthens…
The new peer-reviewed paper can help inform the development of new vaccines and therapeutics. When SARS-CoV-2, the virus that causes COVID-19 disease, first appeared, it…
UC San Diego researchers describe an imbalance of opposing cell signals that cause deadly disease, and how a novel monoclonal antibody therapy might treat or…
A study investigating samples of the superbug Clostridioides difficile across 14 pig farms in Denmark finds the sharing of multiple antibiotic-resistance genes between pigs and human patients, providing…
New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study will be presented…
A new biodegradable gel improves the immune system’s ability to keep cancer at bay after tumors are surgically removed. The gel, tested in mice, releases…
Although SARS-CoV-2 (the virus that causes COVID-19) has taken the world by storm, it’s not the only coronavirus that can infect humans. But unlike SARS-CoV-2,…
Treating women diagnosed with one type of early-stage breast cancer with the monoclonal antibody trastuzumab after surgery reduces the risk of the cancer returning, reports…
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at…